AzTrials
AzTrials

Infant, NewbornNCT02064712

Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates

A study testing Low CPAP Wean and High CPAP Wean in people with Infant, Newborn and Infant, Premature, run by University of Texas Southwestern Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher settings. Read more about this study

Who is it for?
Ages Up to 32 weeks
Conditions the study is for
Infant, Newborn, Infant, Premature
What is being tested?
Low CPAP Wean and High CPAP Wean
Could I receive a placebo?
No, everyone receives an active treatment
How many people
226 participants
Where
1 siteUnited States
Study dates
Sep 2014to Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 32 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Neonates ≤32wks GA requiring NCPAP in the delivery room or NICU for increasing respiratory distress or post-extubation from mechanical ventilation.

Who cannot join

  • Neonates requiring NCPAP for less than 48 hours
  • Congenital anomalies
  • Need for surgery
  • Transfer to a different facility
  • Grade 3-4 intraventricular hemorrhage

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Parkland Memorial Hospital

    Dallas, Texas, 75235

Other trials in United States

About this study

The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher settings.

Read the detailed description

This is a prospective randomized control trial to investigate an optimal method for discontinuing NCPAP therapy in preterm neonates. Neonates ≤32 weeks gestational age (GA) who require NCPAP in the delivery room or following extubation and are delivered in or transferred to Parkland Hospital Neonatal Intensive Care Unit (NICU) will be enrolled. The study team will approach the parents for verbal consent once neonates are stable on mechanical ventilation with a goal of extubation to NCPAP or once they are placed on initial NCPAP therapy. Neonates will be randomized to the high or low NCPAP arms and managed by their primary care team until they meet stability criteria as defined for a minimum of 12 hours. At that time they will be removed from NCPAP using two approaches: Group 1 will be decreased to 5cm H2O by the primary care team at which time NCPAP is removed if the neonate is clinically stable and the neonate placed in room air or on low-flow nasal cannula at ≤1L/min; Group 2 will be gradually weaned to a NCPAP of 3cm H2O at which time NCPAP is removed if the neonate is clinically stable for the prior 24 hours and the neonate placed in room air or on low-flow nasal cannula. Failure criteria will consist of clinical signs and laboratory results demonstrating the need for escalation of support, e.g., increasing apnea of prematurity (AOP) or need for increasing O2 supplementation. When a neonate has been stable for 5 days off NCPAP, they will complete the intervention arm of the study. All neonates will be followed until discharge, at which time the primary outcomes, e.g., days on NCPAP, duration of hospitalization and need for O2, will be determined for each group and compared. The calculated total sample size will require 238 neonates; i.e., 113 neonates per arm with a 5% drop-out rate will give a power of 0.80 and alpha value of 0.05 to detect a 25% difference in NCPAP days.

Stability Criteria:

  1. NCPAP 5cm H2O
  2. Supplemental oxygen <25% and not increasing
  3. Respiratory rate ≤60 b/min
  4. No significant respiratory distress, e.g., retractions, dyspnea
  5. <3 episodes of apnea (>20 seconds) with bradycardia (<100 beats/min), and/or desaturations (<88%) within 1h or <5 episodes in prior 12h
  6. Average oxygen saturation >87% with stable inspired O2
  7. Tolerate time off NCPAP during routine care procedures
  8. Neonates <27 wks GA must be ≥10d postnatal before weaning

Failure Criteria:

  1. Occurrence of ≥3 apneas and/or bradycardia and/or desaturations within 1h or >4 episodes in a 12h period
  2. Increasing need for supplemental O2 >30% to maintain O2 saturation >87%
  3. Increase in the PaCO2 >65 mmHg
  4. Increased work of breathing with respiratory rate >75 b/min for >2h
  5. AOP requiring resuscitation
  6. Initiation of nasal intermittent positive pressure ventilation (NIPPV) for respiratory support
Being tested
Low CPAP Wean, High CPAP Wean
Keywords
Continuous Positive Airway Pressure
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low CPAP WeanOther

    Infants receive NCPAP by Hudson nasal prongs.

  • High CPAP WeanOther

    Infants receive NCPAP by Hudson nasal prongs.

Study groups in NCT02064712
Study groupRoleWhat they receive
Low CPAP WeanActive comparatorNCPAP weaned to 5cm H2O for minimum of 24h, and if the neonate remains clinically stable as defined, wean in 1cm increments to 3cm H2O for minimum of 24h, at which time move to room air or 1L/min nasal cannula if supplemental O2 is required.
Receives: Other: Low CPAP Wean
High CPAP WeanActive comparatorNCPAP weaned to 5cm H2O for a minimum of 24h, and if the neonate remains clinically stable, move to room air or 1L/min nasal cannula if supplemental O2 is required.
Receives: Other: High CPAP Wean

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total days of NCPAP

    Total number of days of CPAP therapy during the hospital stay

    Measured: Until hospital discharge or 1 year of life

Secondary outcomes (2)
  1. Length of hospital stay

    Number of days spent prior to being discharged from the hospital

    Measured: Until hospital discharge or 1 year of life

  2. Duration of oxygen supplementation

    Number of days

    Measured: Until hospital discharge or 1 year of life

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2014 (estimated)
  2. Study startSep 2014
  3. Primary completionMay 2018
  4. Study completionOct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
226 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02064712
Sponsor's protocol ID
NCPAPwean
Status last verified
Oct 2018
First submitted
14 Feb 2014
Last updated
22 Oct 2018
Results posted
No
Data monitoring committee
No

Publications

  • Kakkilaya V, Tang A, Wagner S, Ridpath J, Ibrahim J, Brown LS, Rosenfeld CR. Discontinuing Nasal Continuous Positive Airway Pressure in Infants </=32 Weeks of Gestational Age: A Randomized Control Trial. J Pediatr. 2021 Mar;230:93-99.e3. doi: 10.1016/j.jpeds.2020.10.045. Epub 2020 Oct 28.

    PubMed 33127365

Questions about this trial

What is this clinical trial studying?

A study testing Low CPAP Wean and High CPAP Wean in people with Infant, Newborn and Infant, Premature, run by University of Texas Southwestern Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total days of NCPAP (time frame: Until hospital discharge or 1 year of life). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02064712, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in